Zepp Health (ZEPP) and Its Peers Head-To-Head Comparison

Zepp Health (NYSE:ZEPP) is one of 60 publicly-traded companies in the “MEDICAL INFO SYS” industry, but how does it compare to its rivals? We will compare Zepp Health to similar companies based on the strength of its risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Profitability

This table compares Zepp Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zepp Health	-44.54%	-23.60%	-11.98%
Zepp Health Competitors	-194.24%	-97.38%	-20.44%

Valuation and Earnings

This table compares Zepp Health and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Zepp Health	$182.60 million	-$75.73 million	-0.50
Zepp Health Competitors	$418.70 million	-$61.27 million	5.56

Zepp Health’s rivals have higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Zepp Health and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	0	0	1	0	3.00
Zepp Health Competitors	250	734	1822	23	2.57

Zepp Health presently has a consensus price target of $13.87, indicating a potential upside of 450.40%. As a group, “MEDICAL INFO SYS” companies have a potential upside of 25.93%. Given Zepp Health’s stronger consensus rating and higher probable upside, analysts plainly believe Zepp Health is more favorable than its rivals.

Institutional and Insider Ownership

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 42.3% of shares of all “MEDICAL INFO SYS” companies are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 18.3% of shares of all “MEDICAL INFO SYS” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

Zepp Health has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Zepp Health’s rivals have a beta of 1.84, indicating that their average share price is 84% more volatile than the S&P 500.

Summary

Zepp Health beats its rivals on 8 of the 13 factors compared.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.